Insight into therapy-related malignancies
Childhood cancer survivors often present with therapy-related malignancies as a result of exposure to chemotherapy or radiotherapy. However, the mechanistic details of how these secondary malignancies emerge are poorly understood. The scope of the EU-funded SecondCANCERinKIDS project is to investigate how mutations accumulate in hematopoietic stem cells and give rise to therapy-related myeloid malignancies (t-MNs). For this purpose, scientists will study hematopoietic cell lineages in children before and after they receive chemotherapy to determine whether the malignant clones pre-existed or were generated as a consequence of treatment. The results will show how chemotherapy affects blood composition and provide novel insights into the origin of cancer.
Fields of science
Call for proposal
See other projects for this call